LettersFull Access
Published Online:1 Oct 2012https://doi.org/10.1176/appi.neuropsych.11110348
- Cited by
- 14 February 2024 | ACS Medicinal Chemistry Letters, Vol. 15, No. 3
- 11 July 2023 | Clinical Medicine Insights: Case Reports, Vol. 16
- Best Practice & Research Clinical Endocrinology & Metabolism, Vol. 36, No. 6
- Start low, go slowly – mental abnormalities in young prolactinoma patients under cabergoline therapyJournal of Pediatric Endocrinology and Metabolism, Vol. 32, No. 9
- Rodrigo Pérez-Esparza,
M.D., M.Sc. , - Carlos Alberto Rojas-Guerrero,
M.D. , - Gerson Geovany Andino-Rios,
M.D. , - Patricia Arias-Garro,
M.D. , - Jesús Ramírez-Bermúdez,
M.D., Ph.D. , - Lesly Portocarrero-Ortiz,
M.D., M.Sc.
27 February 2017 | The Journal of Neuropsychiatry and Clinical Neurosciences, Vol. 29, No. 3- Rodrigo Pérez-Esparza,
- 14 June 2016 | Australian and New Zealand Journal of Obstetrics and Gynaecology, Vol. 56, No. 4
- 2 March 2013 | Reactions Weekly, Vol. 1441, No. 1
Metrics
None of the authors have any relevant conflicts of interests to disclose.
History
Published online 1 October 2012
Published in print 1 October 2012